SSGJ-707tislelizumab
…as ‘related,’ ‘most possibly related,’ or ‘possibly related’ to SSGJ-707 or tislelizumab.Abstract 1328 Figure 1Waterfall plots for SSGJ-…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 17 of 2459T1Dinsulin pump therapydiabetesdiabetic ketoacidosisUniversity of Texas Southwestern Medical Centermonogenic diabetes
… sugar during exercise5 (3–5)5 (4–5)4 (3–5)3B. BurCGM scores of T1D patients by race/ethnicityNHWNHBHispanicn=30n=32n=41I think…Med…
lupus nephritislupus nephritisDescribeGLP-1 RAtype 2 diabetes
…itors or ARBs) are the foundational nephroprotective therapy in lupus nephritis with persistent proteinuria, and should be initiated in all pat…
Tranexamic acidoxytocinObstetric haemorrhageoxytocin1cardiac arrestCarbetocinmisoprostol
…may be the cause, or occur as a result, of massive haemorrhage. Tranexamic acid is recommended for clot stabilization, with greatest mortality …
oncologycancerCONSORT-AIartificial intelligence interventionCONSORT-AI
…onsistent, transparent and comprehensive reporting in AI-driven oncology trials is essential to building trust in these promising techno…
CerebrovaKPPhenoxBrainomixLuminopiaVastrax
…ltants, 3N Endovascular, Basecampv Vascular SAS, Borvo Medical, CerebrovaKP, Code Zero, Collavidence, Contego, FreeOx Biotech, Hyperion Sur…
TenecteplaseAlteplaseTNKtPAAIS
… thrombolytic administered within 4.5 hours of stroke symptoms. Tenecteplase (TNK) is FDA-approved for STEMI, but its off-label use for AIS …
Visual Analogue Scalehypoglycemic treatmentEuropean CommissioninsulinSwinburne UniversityType 2 diabetesdiabetesfoot ulcersEQ-5Dperiodontal disease+4 more
…tivities, pain/discomfort and anxiety/depression and includes a visual analog scale (score from 1 to 100).21 22The following diabetes-related compl…
SGLT2itype 2 diabetes
…therapy with SGLT2i and GLP-1 RA relative to those who received SGLT2i monotherapy was significantly lower in patients with HF and T2D…
belimumabsystemic lupus erythematosusanifrolumabsystemic lupus erythematosusApplySLE
…arning Objectives Discuss the different mechanisms of action of belimumab and anifrolumab and their roles in modulating immune pathways i…
UK BiobankFinnGendiabetic retinopathyGlobal Lipids Genetics ConsortiumPDRfull-course DRdiabetesDR
…s were extracted from the Global Lipids Genetics Consortium and UK Biobank. Summary-level data of full-course DR are obtained from FinnGen…
ABBV-368nab-paclitaxelR/M HNSCCbudigalimab
…y receptor OX40. Here, we investigate a treatment strategy with ABBV-368 combined with the investigational toll-like receptor 9 agonist …